AgomAb Therapeutics NV (AGMB) Receivables - Net (2024 - 2025)
Agomab Therapeutics (AGMB) recorded Receivables - Net of $4.67 million in Q4 2025, up 117.5% from $2.15 million a year earlier.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Receivables - Net (2024 - 2025) Analysis & Trends
At the end of FY2025, Agomab Therapeutics reported Receivables - Net of $4.53 million, up 108.4% from FY2024.
- Across earlier years, Receivables - Net came in at $2.17 million in FY2024.
Peer Set
Peer Comparison
API Access
AgomAb Therapeutics NV Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();